The most problematic symptoms of prion disease - an analysis of carer experiences.


Journal

International psychogeriatrics
ISSN: 1741-203X
Titre abrégé: Int Psychogeriatr
Pays: England
ID NLM: 9007918

Informations de publication

Date de publication:
08 2019
Historique:
pubmed: 26 10 2018
medline: 4 4 2020
entrez: 25 10 2018
Statut: ppublish

Résumé

Prion diseases are rare dementias that most commonly occur sporadically, but can be inherited or acquired, and for which there is no cure. We sought to understand which prion disease symptoms are most problematic for carers, to inform the development of outcome measures. Self-completed questionnaire with follow-up of a subset of participants by structured interview. A nested study in the UK National Prion Monitoring Cohort, a longitudinal observational study. 71 carers, of people with different prion diseases with a wide range of disease severity, identified 236 of their four most problematic symptoms by questionnaire which were grouped into ten domains. Structured interviews were then done to qualitatively explore these experiences. Eleven family carers of people with prion disease were selected, including those representative of a range of demographics and disease subtypes and those who cared for people with prion disease, living or recently deceased. Interviews were transcribed and formally studied. The six most problematic symptom domains were: mobility and coordination; mood and behavior; personal care and continence; eating and swallowing; communication; and cognition and memory. The prevalence of these symptoms varied significantly by disease stage and type. A formal analysis of structured interviews to explore these domains is reported. We make suggestions about how healthcare professionals can focus their support for people with prion disease. Clinical trials that aim to generate evidence regarding therapies that might confer meaningful benefits to carers should consider including outcome measures that monitor the symptomatic domains we have identified as problematic.

Identifiants

pubmed: 30353798
pii: S1041610218001588
doi: 10.1017/S1041610218001588
pmc: PMC6372072
mid: EMS79117
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1181-1190

Subventions

Organisme : Medical Research Council
ID : G0400713
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00024/1
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom

Références

Int Psychogeriatr. 2018 Mar;30(3):281-283
pubmed: 29616607
Am J Psychiatry. 2014 Mar;171(3):265-74
pubmed: 24585329
J Gerontol. 1982 May;37(3):323-9
pubmed: 7069156
Nurse Res. 2004;12(1):47-61
pubmed: 15493214
Nurse Res. 2011;18(2):19-27
pubmed: 21319481
Annu Rev Neurosci. 2001;24:519-50
pubmed: 11283320
BMJ. 1997 Sep 20;315(7110):740-3
pubmed: 9314762
BMJ. 2011 Jul 15;343:d4065
pubmed: 21765198
Int Psychogeriatr. 2016 Feb;28(2):269-73
pubmed: 26435062
Qual Health Res. 2006 Dec;16(10):1371-85
pubmed: 17079799
Nurse Res. 2011;19(1):12-6
pubmed: 22128582
Age Ageing. 1996 Mar;25(2):113-20
pubmed: 8670538
Lancet. 2017 Dec 16;390(10113):2673-2734
pubmed: 28735855
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Brain. 2013 Apr;136(Pt 4):1116-27
pubmed: 23550114
J Clin Epidemiol. 2007 Jan;60(1):34-42
pubmed: 17161752
Nurse Res. 2004;12(1):7-19
pubmed: 15493211
J Neurol Neurosurg Psychiatry. 2009 Jan;80(1):7-12
pubmed: 19091706
Neurology. 2011 Nov 1;77(18):1674-83
pubmed: 22013183
Brain. 2006 Sep;129(Pt 9):2241-65
pubmed: 16816391
Int Psychogeriatr. 2018 Nov;30(11):1649-1670
pubmed: 29667568

Auteurs

Liz Ford (L)

NHS National Prion Clinic, National Hospital for Neurology and Neurosurgery, University College London (UCL) Hospitals NHS Foundation Trust, London, UK.

Peter Rudge (P)

NHS National Prion Clinic, National Hospital for Neurology and Neurosurgery, University College London (UCL) Hospitals NHS Foundation Trust, London, UK.
MRC Prion Unit at UCL, Institute of Prion Diseases, UCL, London, UK.

Kathy Robinson (K)

The Open University, Milton Keynes, UK.

John Collinge (J)

NHS National Prion Clinic, National Hospital for Neurology and Neurosurgery, University College London (UCL) Hospitals NHS Foundation Trust, London, UK.
MRC Prion Unit at UCL, Institute of Prion Diseases, UCL, London, UK.

Michele Gorham (M)

NHS National Prion Clinic, National Hospital for Neurology and Neurosurgery, University College London (UCL) Hospitals NHS Foundation Trust, London, UK.

Simon Mead (S)

NHS National Prion Clinic, National Hospital for Neurology and Neurosurgery, University College London (UCL) Hospitals NHS Foundation Trust, London, UK.
MRC Prion Unit at UCL, Institute of Prion Diseases, UCL, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH